Skip to content

Medi-Port Pilot Randomized Controlled Trial

Using a Humanoid Robot to Reduce Procedural Pain and Distress in Children With Cancer: A Pilot Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02611739
Enrollment
40
Registered
2015-11-23
Start date
2016-01-31
Completion date
2016-12-31
Last updated
2018-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

4-9 Years of Age, Able to Speak and Understand English, Actively Undergoing Cancer Treatment, At Least 1 Month From Diagnosis, Presenting to Clinic for at Least a 2nd Subcutaneous Port Needle Insertion

Brief summary

Pain is a frequent and significant problem related to cancer-directed treatment in children. Children with cancer often cite needle procedures as the most distressing experience caused by cancer and its treatment. Recently it has been shown that an interactive humanoid robot is capable of facilitating distraction and reducing distress during childhood immunizations. Our research objectives are to: (1) assess the feasibility of implementing the robot (Medi-Port) for effectiveness testing in a future RCT (measured as implementation outcomes) and (2) determine treatment effectiveness estimates (measured as preliminary effectiveness outcomes), compared to standard medical care.

Detailed description

A sample of 40 children with cancer between the ages of 4-9 years (20 participants per treatment arm; 10 boys and 10 girls per treatment arm) will be recruited. The feasibility of the trial protocol to evaluate the impact of distraction via the humanoid robot on pain intensity and distress during SCP needle insertion compared to an active control in children with cancer will be explored. The effectiveness outcome includes the examination of the robot programmed to distract children during the procedure, reduce pain intensity and distress compared to an active control intervention (i.e. dancing robot).

Interventions

DEVICEMedi-Port

Treatment

Sponsors

University of Calgary
CollaboratorOTHER
The Hospital for Sick Children
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
4 Years to 9 Years
Healthy volunteers
No

Inclusion criteria

* 4-9 years * able to speak and understand English, * actively undergoing cancer treatment * presenting to clinic for at least a 2nd subcutaneous port needle insertion * being at least 1 month from diagnosis.

Exclusion criteria

* visual, auditory or cognitive impairments precluding interaction with Medi-Port * end-of-life patients * patients who are nil per os pre-sedation.

Design outcomes

Primary

MeasureTime frameDescription
Time12 monthsPractical difficulties will be captured using the Medi-Port Intervention Log, designed to record data.
Technical difficulties12 monthsTechnical difficulties (occurrence and description) will be captured using the Medi-Port Intervention Log, designed to record data.
Practical difficulties12 monthsPractical difficulties will be captured using the Medi-Port Intervention Log, designed to record data.
Accrual rates12 monthsAccrual rates will be captured by recording data related to the number of eligible children per recruitment day, reasons for ineligibility, and reasons for non-participation.
Acceptability12 monthsAcceptability will be measured using the Medi-Port Satisfaction Questionnaire completed by children, parent, and nurses that will collect data on acceptability, perceived utility of pain reducing procedures, and recommendations for changes related to the needle insertion experience.
Outcome measure feasibility12 monthsOutcome measure feasibility will be measured as the percentage of completed outcome measures at baseline and study completion (100% when all questionnaires are completed) and will be recorded on Medi-Port Activity Log.

Secondary

MeasureTime frameDescription
Distress12 monthsDistress (both retrospectively for previous SCP access and after the study procedures will be measured). Children will retrospectively report fear using the Children's Fear Scale (CFS), which is a visual scale with established psychometrics in children 5-10 years. Parents will retrospectively report pain using an 11-point NRS. Distress during the study SCP access will be measured using the observer-rated Behavioral Approach-Avoidance Scale (BAADS). The same 2 trained research team members will code video-recordings from all SCP needle insertions using the BAADS. Child distress behaviours will be scored at specific steps during the procedure: 1) nurse movement towards the child 2) pre-procedure skin sterilization 3) SCP position assessment by nurse 4) needle insertion 5) sterile dressing application.
Pain intensity12 monthsPain intensity (both retrospectively for previous SCP access and after the study procedures) will be measured. Children will self-report their pain and parents, nurses, and the researcher will use proxy-reporting in rating children's pain. Children will use the Faces Pain Scale-Revised (FPS-R) which has been validated in children 4 years and older. Parents, nurses, and the researcher will use an 11-point numerical rating scale (NRS), with verbal anchors of no pain at all at 0 and the most pain you can imagine this child having at 10.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026